NEW YORK (GenomeWeb News) – The Broad Institute says cramped quarters at its three existing Cambridge, Mass., sites prompted it to sign a 10-year lease for 80,000 square feet less than 10 minutes away in the same city.

Broad is set to move some of its operations and staff into part of 301 Binney St., "during the late summer of 2010," Nicole Davis, a spokeswoman for the institute, told GenomeWeb Daily News. "We're pretty tight on space right now, so we're expanding."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.